Brief: Supriya Lifescience Gets Certification Of Suitability From Europe Agency For Diphenhydramine Hydrochloride
28/09/2022 14:01
Sept 28 (Reuters) - Supriya Lifescience Ltd SPRL.NS :
* EDQM GRANTED CERTIFICATION OF SUITABILITY FOR
DIPHENHYDRAMINE
HYDROCHLORIDE, API IN ANTIHISTAMINE THERAPY
Source text for Eikon: ID:
Further company coverage: SPRL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit